Rationale: Volatile organic compounds present in the exhaled breath have shown promise
as biomarkers of lung cancer. Advances in colorimetric sensor array technology, breath …

Breath is considered to be an easily accessible matrix, whose chemical composition relates
to compounds present in blood. Therefore many metabolites are expected in exhaled …

There is increasing interest in the development of noninvasive diagnostic methods for early
cancer detection, to improve the survival rate and quality of life of cancer patients …

There has been growing interest in exhaled breath analysis for cancer screening and
disease monitoring; however, limited breath biomarker information exists regarding …

The aim of the present study was to compare the efficiency of targeted and untargeted
breath analysis in the discrimination of lung cancer (Ca+) patients from healthy people (HC) …

Exhaled breath analysis, with particular emphasis on volatile organic compounds,
represents a growing area of clinical research due to its obvious advantages over other …

Background Conventional methods for lung cancer detection including computed
tomography (CT) and bronchoscopy are expensive and invasive. Thus, there is still a need …

Objectives Developing screening and diagnosis methodologies based on novel biomarkers
should allow for the detection of the lung cancer (LC) and possibly at an earlier stage and …

Background Timely diagnosis of cancer represents a challenging task; in particular, there is
a need for reliable non-invasive screening tools that could achieve high levels of adherence …

Detecting exhaled volatile organic compounds (VOCs) that are associated with lung cancer
(LC) has realistic potential for becoming an integral part of population-based LC screening …